Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy

Clinical trial NCT07410169 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07410169
Sponsor: Guangdong Provincial People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Breast Cancer CIPN - Chemotherapy-Induced Peripheral Neuropathy Paclitaxel-induced Peripheral Neuropathy

Start date: 2026-01-31
Primary completion: 2027-12-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.